Hematologist ·
Sheba Medical Center , Ramat Gan, Israel
30 Years of experience ·
Languages Spoken: Hebrew , English
Book a secure video consultation for expert Transplant Surgeon care.
Upload MRI/CT scans, laboratory reports, prescriptions, and previous medical records. Supported formats: PDF, JPEG, and DICOM.
Consult the Doctor in your preferred language. A family member or caregiver is welcome to join.
Receive a signed medical opinion with diagnosis, treatment recommendations, and next steps in a downloadable PDF.
If needed, our team can assist with a second opinion, hospital appointments, or medical travel arrangements.
Dr. Amos Toren is available to teleconsult on the MediGence platform.
The consultation can last from 15 to 30 minutes. It may exceed the estimated time, depending on the patient’s queries and the doctor's medical suggestions.
We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organised within 24 to 48 hours or based on the availability of the doctor and the patient.
No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.
The option to share your medical records is available between the steps of the form provided to you on the website.
Yes. If you are satisfied with the consultation, you can go ahead with treatment packages for your diagnosis with the help of our case managers.
Yes. The cost estimate will be provided to you by our case manager, including the doctor’s opinion, the cost estimate, and crucial information about travelling to your medical destination.
Pediatric Hemato-Oncology is a medical speciality that focuses on diagnosing and treating blood disorders (haematology) and cancers (oncology) in children, adolescents, and young adults. This includes leukaemia, lymphoma, solid tumours, and blood diseases like anaemia or clotting disorders.
Treatment varies based on the type and stage of cancer, and may include:
CAR T-cell therapy is an advanced immunotherapy that involves modifying a patient’s T-cells to recognise and attack cancer cells, especially effective in certain types of relapsed or resistant leukaemia and lymphoma.
Yes, many childhood cancers have high cure rates, especially when diagnosed early and treated at specialised centres. Advances in research and personalised medicine have significantly improved survival rates.
Dr. Shagufta Parveen is a Clinical researcher and medical writer with expertise in clinical pharmacology and pharmacotherapeutics. She holds a B.Pharm and Doctor of Pharmacy (Post-Baccalaureate) degree from Teerthanker Mahaveer University, Moradabad.
During her clinical stint at BLK-Max Super Speciality Hospital and Indraprastha Apollo Hospital, she gained hands-on experience in the Clinical Pharmacology Department. Combining scientific knowledge with strong medical writing skills, Dr. Shagufta develops evidence-based healthcare content, treatment guides, and patient education resources.
Her work focuses on simplifying complex medical concepts while maintaining scientific accuracy, helping readers better understand healthcare advancements and treatment options.
In addition to her writing expertise, she is actively involved in scientific research and has contributed to peer-reviewed publications.
Her research work is accessible through the following links:
https://scholar.google.com/citations?user=lMVK1eIAAAAJ&hl=en
https://carcinogenesis.com/index.php/JOC/article/view/870
Have your reports reviewed by independent oncology experts to help you make a confident treatment decision, all online within 48 hours